NEW YORK (GenomeWeb News) - Plant genomics company Ceres has raised $75 million through a private offering of convertible stock led by the private equity firm Warburg Pincus, Ceres said today.
 
Ceres plans to use the funds to develop crops bred to maximize biomass that may be used for biofuels, and for capital expenditures and for corporate purposes.
 
Ceres said its development efforts include biofuel crops such as switchgrass, sorghum, miscanthus, energycane, and woody species.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.